Nalaganje...
Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
Sodium glucose transporter 2 (SGLT2) inhibitors are a recently developed class of drug that have been approved for use in type 2 diabetes. Their unique extra-pancreatic glucuretic mode of action has encouraged their usage in type 1 diabetes as well. At the same time, reports of pseudo ketoacidosis a...
Shranjeno v:
| izdano v: | Indian J Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications & Media Pvt Ltd
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4481661/ https://ncbi.nlm.nih.gov/pubmed/26180770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.157859 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|